PTEN inhibition induces neuronal differentiation and neuritogenesis in SH-SY5Y cells via AKT signaling pathway
- PMID: 40598859
- DOI: 10.1177/13872877251352194
PTEN inhibition induces neuronal differentiation and neuritogenesis in SH-SY5Y cells via AKT signaling pathway
Abstract
BackgroundPTEN is a key regulator of neuronal differentiation and neurogenesis. Its role in modulating the PI3K/AKT pathway and oxidative stress responses in neuronal models remains an area of active investigation.ObjectiveThis study aimed to assess the effects of PTEN knockdown on neuronal differentiation, neuritic growth, and PI3K/AKT pathway activation in SH-SY5Y cells.MethodsSH-SY5Y cells were treated with PTEN siRNA to induce PTEN knockdown. The level of PTEN inhibition was confirmed, and assays were performed to evaluate neurogenesis and neuritogenesis at 3- and 7-days post-treatment. Protein expression analysis of key components in the AKT/GSK3-β/Tau pathway was conducted to assess their role in neurogenesis. Additionally, the PI3K inhibitor LY294002 was used to examine its impact on PTEN knockdown-induced neuronal differentiation.ResultsPTEN knockdown significantly increased neurite lengths and reduced cytoplasmic size, indicating neuronal differentiation. Protein analysis showed that PTEN inhibition modulated the expression of components in the AKT/GSK3-β/Tau pathway. The PI3K inhibitor LY294002 prevented neuronal differentiation, confirming the involvement of the PI3K/AKT pathway in mediating the effects of PTEN knockdown.ConclusionsOur findings demonstrate that PTEN plays a crucial role in regulating neuronal differentiation in SH-SY5Y cells. The PI3K/AKT pathway mediates the effects of PTEN knockdown, suggesting PTEN as a potential therapeutic target for neurodegenerative diseases where its dysregulation may contribute to disease progression.
Keywords: Alzheimer's disease; PI3K/AKT pathway; PTEN knockdown; tau phosphorylation.
Conflict of interest statement
Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway.J Cancer Res Clin Oncol. 2017 Aug;143(8):1477-1487. doi: 10.1007/s00432-017-2415-5. Epub 2017 Apr 11. J Cancer Res Clin Oncol. 2017. PMID: 28401302 Free PMC article.
-
Tamibarotene promotes differentiation of neuroblastoma SH-SY5Y cells into neurons, which is associated with activation of the PI3K/AKT signaling pathway.BMC Neurosci. 2025 Jul 15;26(1):41. doi: 10.1186/s12868-025-00962-8. BMC Neurosci. 2025. PMID: 40665231 Free PMC article.
-
HSC70 Promotes Breast Cancer Progression via PTEN Autophagic Degradation and PI3K/AKT/mTOR Activation.Mol Carcinog. 2025 Aug;64(8):1287-1301. doi: 10.1002/mc.23931. Epub 2025 May 14. Mol Carcinog. 2025. PMID: 40369948
-
Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer.J Cancer Res Clin Oncol. 2015 Apr;141(4):671-89. doi: 10.1007/s00432-014-1803-3. Epub 2014 Aug 22. J Cancer Res Clin Oncol. 2015. PMID: 25146530 Free PMC article. Review.
-
Melatonin effect on breast and ovarian cancers by targeting the PI3K/Akt/mTOR pathway.IUBMB Life. 2024 Dec;76(12):1035-1049. doi: 10.1002/iub.2900. Epub 2024 Aug 30. IUBMB Life. 2024. PMID: 39212097 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials